Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 100 mg/2% suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 200 mg/2% suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 100 mg/mL intramuscular solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Benzocaine + trimethobenzamide hydrochlor 2%ww/100mg suppositories |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Product containing benzocaine and trimethobenzamide hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely trimethobenzamide hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Product containing trimethobenzamide hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 100mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 200mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 100mg suppositories |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 100mg/mL bar |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 200 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trimethobenzamide hydrochloride |
Inferred relationship |
Some |
1 |